This inventor holds 1 USPTO granted patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Innovations of Tatsuhiko Iwase in Gastroparesis Treatment
Introduction
Tatsuhiko Iwase is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of gastroparesis symptoms. His innovative approach has led to the development of a therapeutic agent that offers a promising solution for patients suffering from this condition.
Latest Patents
Iwase holds a patent for a drug aimed at the treatment and/or prophylaxis of gastroparesis symptoms. The invention provides a therapeutic and preventive agent that is suitable for continuous medication. It comprises a compound represented by a specific formula, which includes a C-Calkyl group as an active ingredient. This erythromycin derivative has shown efficacy in improving gastroparesis symptoms, distinguishing itself from other motilin agonist derivatives like ABT-229. Furthermore, the compound is deemed appropriate for long-term clinical use due to its significantly weaker antibacterial action compared to erythromycin. This innovation presents a safe pharmaceutical agent with potent therapeutic effects for symptomatic gastroparesis.
Career Highlights
Tatsuhiko Iwase is associated with Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company. His work there has been instrumental in advancing research and development in the field of gastrointestinal treatments. Iwase's dedication to improving patient outcomes through innovative drug development is commendable.
Collaborations
Iwase has collaborated with notable colleagues such as Osamu Cynshi and Hisanori Takanashi. Their combined expertise has contributed to the successful development of effective pharmaceutical solutions.
Conclusion
Tatsuhiko Iwase's contributions to the treatment of gastroparesis through his innovative patent highlight the importance of research in pharmaceuticals. His work not only addresses a significant medical need but also showcases the potential for advancements in therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile